← SynDRA
BICALUTAMIDE
SynDRA canonical compound SYN0000050 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | AR |
| Mechanism of action | Androgen receptor antagonist |
| Indication | prostate cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
Drug classes
- Androgen Receptor Antagonists
- Androgen Receptor Inhibitor
- Androgen Antagonists
- Antineoplastic Agents
- Hormone Antagonists
ATC classes
- L02B · HORMONE ANTAGONISTS AND RELATED AGENTS
- HORMONES AND RELATED AGENTS
Cross-references
Synonyms
- ICI-176334
- casodex
- Bicalutamida
- ICI 176,334
- ICI176,334-1
- NSC-759816
- Calutide
- Casodex
- Cosudex
- Kalumid
- Propanamide
- Raffolutil
- Astra brand of bicalutamide
- AstraZeneca brand of bicalutamide
- Zeneca brand of bicalutamide
- Calutide (TN)
- Casodex (TN)
- Cosudex (TN)
- KS-1161
- Kalumid (TN)
- Bicalutamide [USAN:INN:BAN]
- Bicalutamide (JAN/USP/INN)
- Casodex, Cosudex, Calutide, Kalumid, Bicalutamide
- N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide
- (+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide
- 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide
- Bicalutamide (CDX)
- N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide
- A0Z3NAU9DP
- CHEMBL409
- NSC 759816
- N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide
- Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-
- SMR000466329
- SR-01000759410
- UNII-A0Z3NAU9DP
- BRN 5364666
- Bicalutamine
Reported adverse events
- Asthenia
- Dyspepsia
- Rash
- Somnolence
- Constipation
- Flatulence
- Nausea
- Headache
- Nocturia
- Pneumonia
- Vomiting
- Alopecia
Look up BICALUTAMIDE in the interactive SynDRA portal →